Jo Caers

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Renato Zambello

ITALY

View details

Philippe Moreau

FRANCE

View details

Artur Jurczyszyn

POLAND

View details

Carlos Fernandez de Larrea Rodriguez

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

SPAIN

View details

Meike Vogler

Goethe University Frankfurt

GERMANY

View details

Gregory Ehx

University of Liege

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jo Caers

Research Interests

Explore related searches

Contact this professor

Articles (6)

Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel

Extramedullary disease in multiple myeloma: a systematic literature review

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology & Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

The Road to a Cure: Emerging Treatments for Multiple Myeloma

Collaborators (6)

Renato Zambello

Philippe Moreau

Artur Jurczyszyn

Carlos Fernandez de Larrea Rodriguez

Meike Vogler

Gregory Ehx

Make your next move.

Jo Caers

Research Interests

Explore related searches

Contact this professor

Articles (6)

Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel

Extramedullary disease in multiple myeloma: a systematic literature review

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology &amp; Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

The Road to a Cure: Emerging Treatments for Multiple Myeloma

Collaborators (6)

Renato Zambello

Philippe Moreau

Artur Jurczyszyn

Carlos Fernandez de Larrea Rodriguez

Meike Vogler

Gregory Ehx

Make your next move.

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology & Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)